This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...